NASDAQ · Medical - Devices

CERS (CERS) Stock

$2.57 -1.15% NASDAQ: CERS Healthcare

Valuation

MetricValue
Price$2.57
Market Cap$517.92M
P/E Ratio-34.25
P/B Ratio8.58
P/S Ratio2.46
EPS (TTM)$0.00
52-Week High$3.44
52-Week Low$1.15
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.00%
ROA-7.21%
ROCE-55.38%
Gross Margin-17.48%
Operating Margin-17.48%
Net Margin-4.29%
Debt/Equity1.44
Current Ratio1.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$131.0M$162.0M$156.0M$180.0M$206.0M
Operating Profit$-49.0M$-34.0M$-30.0M$-14.0M$-36.0M
Net Profit$-54.0M$-43.0M$-37.0M$-21.0M$-16.0M
EPS$-0.32$-0.24$-0.21$-0.11$-0.08
Op Margin-37.4%-21.0%-19.2%-7.9%-17.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$237.0M$218.0M$198.0M$201.0M$222.0M
Total Liabilities$152.0M$150.0M$144.0M$144.0M$157.0M
Cash$49.0M$36.0M$12.0M$20.0M$20.0M
Borrowings$88.0M$87.0M$96.0M$98.0M$97.0M

Latest News

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress Business Wire · Jun 17, 2026 Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M Insider Monkey · Jun 16, 2026 Cerus Corporation Closes New Debt Facility of Up to $110 Million Business Wire · Jun 8, 2026 Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year? Zacks · Jun 4, 2026 Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG Insider Monkey · May 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-26.0M$-43.0M$11.0M$11.0M
Investing Cash Flow$12.0M$6.0M$4.0M$-11.0M$-11.0M
Financing Cash Flow$10.0M$4.0M$1.0M$1.0M$5.0M
Net Cash Flow$12.0M$-14.0M$-24.0M$8.0M$8.0M
Free Cash Flow$-35.0M$-28.0M$-48.0M$9.0M$9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.22%
Quick Ratio1.06
Interest Coverage-4.50
Return 1Y97.93%
Return 3Y0.35%
Return 5Y-35.91%

Ownership

Insiders Held3.40%
Institutions Held73.30%
Institutions Float Held75.89%
Institutional HolderSharesReport Date
Blackrock Inc.21,575,4192026-03-31
ARK Investment Management, LLC19,161,1482026-03-31
Soleus Capital Management, L.P.10,753,7002026-03-31
Baker Bros. Advisors, LP10,008,3452026-03-31
Vanguard Capital Management LLC8,131,7782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CVRX $3.01 -1.95% -2.98 $79.87M 0.00%
MASS $10.04 -2.81% -10.80 $411.91M 0.00%
NPCE $14.75 -2.90% -26.68 $502.88M 0.00%
QTRX $2.58 -1.15% -0.98 $121.53M 0.00%
RXST $6.54 -6.97% -6.22 $270.73M 0.00%

About CERS

CERS is led by CEO William Greenman, employs 614 people, headquartered in US, publicly traded since 1997.

CERS stock trades at $2.57 with a market capitalization of $517.92M. The stock is valued at a price-to-earnings (P/E) ratio of -34.25, price-to-book of 8.58, price-to-sales of 2.46. Over the past 52 weeks the stock has ranged between $1.15 and $3.44, and currently trades 25.3% below its 52-week high.

On profitability, CERS generates a return on equity (ROE) of -25.00%, return on capital employed of -55.38%, an operating margin of -17.48%, a net profit margin of -4.29%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.50 -0.05% JNJ Drug Manufacturers - General $278.43 +1.17% ABBV Drug Manufacturers - General $260.30 -0.54% MRK Drug Manufacturers - General $152.34 +0.46% UNH Medical - Healthcare Plans $400.94 +0.32% NVS Drug Manufacturers - General $163.09 +0.39% AZN Drug Manufacturers - General $164.77 +1.94% AMGN Drug Manufacturers - General $444.12 +0.29% TMO Medical - Diagnostics & Research $618.43 +1.63% NVO Biotechnology $47.51 +1.58% ABT Medical - Devices $108.80 -1.51% GILD Drug Manufacturers - General $151.22 +1.08%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides